| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/27/2008 | CN101133054A 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |
| 02/27/2008 | CN101133036A Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
| 02/27/2008 | CN101133027A Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 02/27/2008 | CN101130526A Aryl carbonyl derivatives as therapeutic agents |
| 02/27/2008 | CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/26/2008 | US7335775 Effector conjugates, process for their production and their pharmaceutical use |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335753 Bifunctional heterocyclic compounds and methods of making and using same |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335674 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 02/26/2008 | US7335670 Specific inhibitors of the glycine transporters glyt1 and/or glyt2; psychoses, contracture, pain, Parkinson's disease, epilepsy, and sleep apnea |
| 02/26/2008 | US7335660 Using a 2-benzopyran-6-carboxamide compound |
| 02/26/2008 | US7335657 Cytokine inhibitors |
| 02/26/2008 | US7335656 Medical devices employing triazine compounds and compositions thereof |
| 02/26/2008 | US7335652 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and\or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/21/2008 | WO2008022002A2 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 02/21/2008 | WO2008021338A2 Tricyclic oxazolidone derivatives useful as pr modulators |
| 02/21/2008 | WO2008021337A1 Oxazinan-2-one derivatives useful as pr modulators |
| 02/21/2008 | WO2008021309A1 Imidazolidin-2-one derivatives useful as pr modulators |
| 02/21/2008 | WO2008020902A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/21/2008 | WO2008020229A2 Antibacterial pyrrolecarboxamides |
| 02/21/2008 | WO2008020227A2 Antibacterial pyrrolecarboxamides |
| 02/21/2008 | WO2008020222A1 Pyrrole derivatives with antibacterial activity |
| 02/21/2008 | WO2008019477A1 Viral polymerase inhibitors |
| 02/21/2008 | WO2007146981A3 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 02/21/2008 | WO2007130064A8 2-n-(5-[[4-(2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
| 02/21/2008 | WO2007121389A3 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors |
| 02/21/2008 | WO2007101213A3 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 02/21/2008 | WO2006130493A8 Heterocycles useful as modulators of ion channels |
| 02/21/2008 | US20080045578 2-(4,4-Dimethyl-2-oxo-1,3-oxazolidin-3-yl)-4,5-dihydronaphtho[1,2-d] [1,3]thiazole-7-carbonitrile; progesterone receptor (PR); contraception, fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy |
| 02/21/2008 | US20080045577 4-[2-(3,5,5-Trimethyl-2-oxoimidazolidin-1-yl)-1,3-thiazol-4-yl]benzonitrile; 1-[4-(4-Bromophenyl)-1,3-thiazol-2-yl]-3-methylimidazolidin-2-one; contraception, fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas |
| 02/21/2008 | US20080045576 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 02/21/2008 | US20080045560 Pyrrolidine and related derivatives useful as PR modulators |
| 02/21/2008 | US20080045528 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |
| 02/21/2008 | US20080045524 Selective NPY (Y5) antagonists |
| 02/21/2008 | US20080045516 Viral Polymerase Inhibitors |
| 02/21/2008 | US20080045505 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators |
| 02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/21/2008 | US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide |
| 02/21/2008 | CA2660555A1 Viral polymerase inhibitors |
| 02/21/2008 | CA2660318A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activit y and use thereof |
| 02/21/2008 | CA2659299A1 Azetidine compounds |
| 02/21/2008 | CA2659276A1 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 02/21/2008 | CA2659208A1 Oxazolidone derivatives as pr modulators |
| 02/21/2008 | CA2650932A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/20/2008 | EP1889844A2 Polymorphic forms of ziprasidone sulphates |
| 02/20/2008 | EP1889843A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 02/20/2008 | EP1889842A1 Heterocyclic compound |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889619A1 Use of thiadiazolidine-derived compounds as neurogenic agents |
| 02/20/2008 | EP1888576A1 Process for making aztreonam |
| 02/20/2008 | EP1888575A2 Compounds for modulating trpv3 function |
| 02/20/2008 | EP1888574A2 New antibiotic derivatives |
| 02/20/2008 | EP1888573A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors |
| 02/20/2008 | EP1888565A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 02/20/2008 | EP1888558A1 Bicyclic derivatives as modulators of ion channels |
| 02/20/2008 | EP1888547A1 Indane derivatives as modulators of ion channels |
| 02/20/2008 | EP1888546A1 Thiazole derivatives and use thereof |
| 02/20/2008 | EP1888542A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 02/20/2008 | EP1888531A2 (5z)-5-(6-quinoxalinylmethylidene)-2-ý(2,6-dichlorophenyl)amino¨-1,3-thiazol-4(5h)-one |
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | EP1888528A2 Phosphodiesterase 4 inhibitors |
| 02/20/2008 | EP1740569B1 Imidazole derivatives used as tafia inhibitors |
| 02/20/2008 | EP1556381B1 Pyrazole amides for treating hiv infections |
| 02/20/2008 | EP1305310B1 Tartrate salts of thiazolidinedione derivative |
| 02/20/2008 | CN101128460A Tricyclic delta-opioid modulators |
| 02/20/2008 | CN101128457A 凝血酶受体拮抗剂 Thrombin receptor antagonists |
| 02/20/2008 | CN101128445A 4-cyclopropyl-1,2,3-thiadiazole derivative, agrohorticultural plant disease controlling agent, and method for using the same |
| 02/20/2008 | CN101128439A 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 02/20/2008 | CN101128432A Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 02/20/2008 | CN101125853A Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/20/2008 | CN101125852A Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/20/2008 | CN101125851A Novel pharmaceutical |
| 02/20/2008 | CN100369904C 2-(replace- amino)-NOBS HIV prolease inhibitor |
| 02/20/2008 | CN100369903C Five-membered-ring compound |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/19/2008 | US7332614 Process for cross coupling indoles |
| 02/19/2008 | US7332602 Pyridyl substituted heterocycles useful for treating or preventing HCV infection |
| 02/19/2008 | US7332521 Substituted indoles |
| 02/19/2008 | US7332520 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332513 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 02/19/2008 | US7332512 Halogenated nitrobutadienes for controlling animal pests |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332499 N-[(1R)-1-(2-fluoro-4-{1-[(trifluoromethyl)sulfonyl]-1,2,3,4-tetrahydroquinolin-8-yl}phenyl)ethyl]-1-[(trifluoroacetyl)amino]cyclopropanecarboxamide; bradykinin B1 antagonists or inverse agonists; analgesic and antiinflammatory agent; acute and chronic pain |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332354 bioconjugation; luciferins; biopolymer labels |
| 02/19/2008 | CA2207100C Pyrimidine derivatives |
| 02/14/2008 | WO2008018639A2 Glycine transporter inhibitor |
| 02/14/2008 | WO2008017852A1 Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |